These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 17885669

  • 1. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans.
    Lisovsky M, Hoang MP, Dresser KA, Kapur P, Bhawan J, Mahalingam M.
    Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669
    [Abstract] [Full Text] [Related]

  • 2. D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
    Bandarchi B, Ma L, Marginean C, Hafezi S, Zubovits J, Rasty G.
    Mod Pathol; 2010 Mar; 23(3):434-8. PubMed ID: 20062007
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma.
    Lazova R, Moynes R, May D, Scott G.
    Cancer; 1997 Jun 01; 79(11):2115-24. PubMed ID: 9179057
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Dermatofibrosarcoma Darier and Ferrand. Immunohistochemistry study of 38 cases. Research on a specific marker].
    Declerck D, Claye C, Rotteleur G, Lecomte-Houcke M.
    Ann Pathol; 1997 Oct 01; 17(5):324-8. PubMed ID: 9471146
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sclerosing Dermatofibrosarcoma Protuberans Shows Significant Overlap With Sclerotic Fibroma in Both Routine and Immunohistochemical Analysis: A Potential Diagnostic Pitfall.
    Abdaljaleel MY, North JP.
    Am J Dermatopathol; 2017 Feb 01; 39(2):83-88. PubMed ID: 28134725
    [Abstract] [Full Text] [Related]

  • 10. From Morphea to Dermatofibrosarcoma Protuberans.
    Crnarić I, Šitum M, Delaš Aždajić M, Vučić M, Buljan M.
    Acta Dermatovenerol Croat; 2022 Sep 01; 30(2):113-115. PubMed ID: 36254545
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phosphohistone-H3 and Ki67: Useful Markers in Differentiating Dermatofibroma From Dermatofibrosarcoma Protuberans and Atypical Fibrohistiocytic Lesions.
    Agarwal A, Gopinath A, Tetzlaff MT, Prieto VG.
    Am J Dermatopathol; 2017 Jul 01; 39(7):504-507. PubMed ID: 28609344
    [Abstract] [Full Text] [Related]

  • 13. Myxoid dermatofibroma on a great toe: a case report.
    Moon A, Yoon N, Kim HS.
    Int J Clin Exp Pathol; 2015 Jul 01; 8(6):7605-9. PubMed ID: 26261677
    [Abstract] [Full Text] [Related]

  • 14. Expression of CD34 in sclerotic ("plywood") fibromas.
    Hanft VN, Shea CR, McNutt NS, Pullitzer D, Horenstein MG, Prieto VG.
    Am J Dermatopathol; 2000 Feb 01; 22(1):17-21. PubMed ID: 10698210
    [Abstract] [Full Text] [Related]

  • 15. Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.
    Boyle JL, Haupt HM, Stern JB, Multhaupt HA.
    Arch Pathol Lab Med; 2002 Jul 01; 126(7):816-22. PubMed ID: 12088451
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
    West KL, Cardona DM, Su Z, Puri PK.
    Am J Dermatopathol; 2014 May 01; 36(5):414-9. PubMed ID: 24162384
    [Abstract] [Full Text] [Related]

  • 17. [Giant cell fibroblastoma associated with Darier-Ferrand dermatofibrosarcoma in an adult].
    Kourda M, Krichen H, Kennou H, Ben Yahia K, Ben Ayed M, Souissi R.
    Ann Dermatol Venereol; 1998 Apr 01; 125(4):255-6. PubMed ID: 9747262
    [Abstract] [Full Text] [Related]

  • 18. Microphthalmia-associated transcription factor (MiTF): Promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall.
    Mohanty SK, Sharma S, Pradhan D, Kandukuri SR, Farahani N, Barry C, Wu JM, Frishberg D, Balzer B.
    Pathol Res Pract; 2018 Jun 01; 214(6):821-825. PubMed ID: 29773427
    [Abstract] [Full Text] [Related]

  • 19. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34.
    Aiba S, Tabata N, Ishii H, Ootani H, Tagami H.
    Br J Dermatol; 1992 Aug 01; 127(2):79-84. PubMed ID: 1382538
    [Abstract] [Full Text] [Related]

  • 20. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
    Mentzel T, Schärer L, Kazakov DV, Michal M.
    Am J Dermatopathol; 2007 Oct 01; 29(5):443-8. PubMed ID: 17890911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.